Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim D Jones

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2026
Antibody HumanizationTim D Jones
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 9, 2010
Prediction of immunogenicity of therapeutic proteins: validity of computational toolsChristine J Bryson, Tim D Jones, Matthew P Baker
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Deimmunization of monoclonal antibodiesTim D Jones, Laura J Crompton, Frank J Carr, et al.
The Journal of General Virology|February 27, 2003
A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virionS Matthew Cleveland, Lesley McLain, Linda Cheung, et al.
Mabs|January 30, 2016
A comparison of the ability of the human IgG1 allotypes G1m3 and G1m1,17 to stimulate T-cell responses from allotype matched and mismatched donorsCarl I Webster, Christine J Bryson, Edward A Cloake, et al.
Protein Engineering, Design & Selection : PEDS|September 1, 2016
A deimmunised form of the ribotoxin, α-sarcin, lacking CD4+ T cell epitopes and its use as an immunotoxin warheadTim D Jones, Arron R Hearn, Robert G E Holgate, et al.
The Journal of Biological Chemistry|October 31, 2020
Development of a novel mammalian display system for selection of antibodies against membrane proteinsNathan Robertson, Nancy Lopez-Anton, Shalom A Gurjar, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 29, 2004
The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infectionTim D Jones, Marian Hanlon, Beverley J Smith, et al.
Mabs|December 31, 2015
The INNs and outs of antibody nonproprietary namesTim D Jones, Paul J Carter, Andreas Plückthun, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2026
Antibody HumanizationTim D Jones
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 9, 2010
Prediction of immunogenicity of therapeutic proteins: validity of computational toolsChristine J Bryson, Tim D Jones, Matthew P Baker
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Deimmunization of monoclonal antibodiesTim D Jones, Laura J Crompton, Frank J Carr, et al.
The Journal of General Virology|February 27, 2003
A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virionS Matthew Cleveland, Lesley McLain, Linda Cheung, et al.
Mabs|January 30, 2016
A comparison of the ability of the human IgG1 allotypes G1m3 and G1m1,17 to stimulate T-cell responses from allotype matched and mismatched donorsCarl I Webster, Christine J Bryson, Edward A Cloake, et al.
Protein Engineering, Design & Selection : PEDS|September 1, 2016
A deimmunised form of the ribotoxin, α-sarcin, lacking CD4+ T cell epitopes and its use as an immunotoxin warheadTim D Jones, Arron R Hearn, Robert G E Holgate, et al.
The Journal of Biological Chemistry|October 31, 2020
Development of a novel mammalian display system for selection of antibodies against membrane proteinsNathan Robertson, Nancy Lopez-Anton, Shalom A Gurjar, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 29, 2004
The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infectionTim D Jones, Marian Hanlon, Beverley J Smith, et al.
Mabs|December 31, 2015
The INNs and outs of antibody nonproprietary namesTim D Jones, Paul J Carter, Andreas Plückthun, et al.
Pageof 1